http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-145633-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce92a4d2fdab0cc5440f710c3787f38
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-02
filingDate 2007-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8549a5c327276bf5e539e2c4617e8fc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9982a927f8ffe5b059082b1cd9166c25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d08d23b844b27bdd9601aefc4df25c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0550de8b8d0a77ba41e26de53025e68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14c2b76fdb64322a0f949ff4c208886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d537e8eb195f826a3d29d6f8faa25d9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de2e01b3c4c1dc9cf3dca6bb62f957f0
publicationDate 2012-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-145633-A
titleOfInvention 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
abstract THE INVENTION PROVIDES NOVEL 8-AZABICYCLO[3.2.1 ]OCTANE COMPOUNDS OF FORMULA (I) WHEREIN R1, R2,R3, A, AND G ARE DEFINED IN THE SPECIFICATION, OR A PHARMACEUTICALLY- ACCEPTABLE SALT OR SOLVATE THEREOF, THAT ARE ANTAGONISTS AT THE MU OPIOID RECEPTOR. THE INVENTION ALSO PROVIDES PHARMACEUTICAL COMPOSITIONS COMPRISING SUCH COMPOUNDS, METHODS OF USING SUCH COMPOUNDS TO TREAT CONDITIONS ASSOCIATED WITH MU OPIOID RECEPTOR ACTIVITY, AND PROCESSES AND INTERMEDIATES USEFUL FOR PREPARING SUCH COMPOUNDS.
priorityDate 2006-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415831418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136097

Total number of triples: 27.